Disease mechanisms of X-linked retinitis pigmentosa due to RP2 and RPGR mutations.
Lyraki R, Megaw R, Hurd T.
Biochem Soc Trans. 2016 Oct 15;44(5):1235-1244. doi: 10.1042/BST20160148.
PMID:27911705
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.
Orlans HO, McClements ME, Barnard AR, Martinez-Fernandez de la Camara C, MacLaren RE.
Nat Commun. 2021 Aug 16;12(1):4934. doi: 10.1038/s41467-021-25204-3.
PMID:34400638
Late-onset mucopolysaccharidosis type IIIA mimicking Usher syndrome.
De Falco A, Karali M, Criscuolo C, Testa F, Barillari MR, Scarpato M, Gaudieri V, Cuocolo A, Russo A, Nigro V, Simonelli F, Banfi S, Brunetti-Pierri N.
Am J Med Genet A. 2024 May;194(5):e63517. doi: 10.1002/ajmg.a.63517. Epub 2023 Dec 27.
PMID:38149346
Laurence-Moon-Bardet Biedl Syndrome With Cholelithiasis.
Kaleem S, Srirangadhamu Gopu S, Ishfaq L, Afroze S, Parvez M, Mulaka GSR, Venugopal V.
Cureus. 2023 Oct 19;15(10):e47316. doi: 10.7759/cureus.47316. eCollection 2023 Oct.
PMID:38021809
A novel frameshift variant in CEP78 associated with nonsyndromic retinitis pigmentosa, and a review of CEP78-related phenotypes.
Lähteenoja L, Häkli S, Tuupanen S, Kuismin O, Palosaari T, Rahikkala E, Falck A.
Ophthalmic Genet. 2022 Apr;43(2):152-158. doi: 10.1080/13816810.2022.2045511. Epub 2022 Mar 3.